Christiane Licht
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Christiane Licht has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Irene Neuner
2 shared publicationsAlexander T. Sack
1 shared publication- Carmen van Meegen
Statistical Consulting and Analysis, Center for Higher Education, TU Dortmund University, 44227 Dortmund, Germany
1 shared publication Dorothee Maria Gescher
1 shared publication- Hartmut Lehfeld
University Clinic for Psychiatry and Psychotherapy, Paracelsus Medical University, 90419 Nuremberg, Germany
1 shared publication Janne Struckmann
1 shared publication
Latest Publications
- Open Access
- 21 September 2026
- Published by Elsevier in Psychiatry Research Case Reports
- Vol. 5 (2)
Sequential dual-site transcranial magnetic stimulation in treatment‑resistant obsessive‑compulsive disorder: A case report
- 21 September 2026
- Published by Elsevier in Psychiatry Research Case Reports
- Vol. 5 (2)
Open AccessSequential dual-site transcranial magnetic stimulation in treatment‑resistant obsessive‑compulsive disorder: A case report
- Open Access
- 13 July 2026
- Published by Elsevier in Journal of Affective Disorders Reports
- Vol. 25
Use of repetitive transcranial magnetic stimulation in a patient with borderline personality disorder: A case report
- 13 July 2026
- Published by Elsevier in Journal of Affective Disorders Reports
- Vol. 25
Open AccessUse of repetitive transcranial magnetic stimulation in a patient with borderline personality disorder: A case report
- Open Access
- 19 March 2026
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 17, 1754397
Case Report: Right−sided vagus nerve stimulation for treatment−resistant affective disorders with complex cardiac comorbidity
Background: Vagus nerve stimulation (VNS) is a well-established treatment option for treatment-resistant affective disorders. Due to potential concerns about increased cardiac innervation on the right side, devices are almost exclusively implanted on the left cervical vagus nerve. Clinical data on right-sided VNS for psychiatric indications are often very scarce. Methods: We present a case series involving three patients—two with MDD and one with bipolar depression—each with extensive prior unsuccessful treatments, frequent hospitalizations, and severe psychiatric and medical comorbidities. In each case, the right cervical side was chosen for primary implantation or re-implantation due to cardiac disease, pre-existing devices, or anatomical constraints (including high-grade atrioventricular block with pacemaker and recurrent laryngeal nerve palsy). All patients underwent standard titration of stimulation parameters and long-term clinical follow-up. Results: All three patients showed significant and lasting mood stabilization within approximately 12 months after right-sided VNS implantation. Hospital admission rates decreased markedly, and in two cases, maintenance electroconvulsive therapy (ECT) was discontinued or notably reduced. In all cases, VNS was generally well tolerated. During right-sided stimulation, no clinically significant bradyarrhythmia, device interactions, or other serious cardiac adverse events were observed. Conclusions: This series highlights the usefulness of right-sided VNS in sustaining long-term mood stability and reducing hospitalizations for patients with highly treatment-resistant, comorbid mood disorders. The findings expand existing epilepsy-focused data on right-sided VNS to the psychiatric field and support systematic evaluation of this approach in future prospective studies. Multidisciplinary coordination is essential to minimize risks and improve outcomes. Additional long-term research is needed to assess its lasting effectiveness, optimal candidate selection, and cost-efficiency in routine clinical practice.
- 19 March 2026
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 17, 1754397
Open AccessCase Report: Right−sided vagus nerve stimulation for treatment−resistant affective disorders with complex cardiac comorbidity
Background: Vagus nerve stimulation (VNS) is a well-established treatment option for treatment-resistant affective disorders. Due to potential concerns about increased cardiac innervation on the right side, devices are almost exclusively implanted on the left cervical vagus nerve. Clinical data on right-sided VNS for psychiatric indications are often very scarce. Methods: We present a case series involving three patients—two with MDD and one with bipolar depression—each with extensive prior unsuccessful treatments, frequent hospitalizations, and severe psychiatric and medical comorbidities. In each case, the right cervical side was chosen for primary implantation or re-implantation due to cardiac disease, pre-existing devices, or anatomical constraints (including high-grade atrioventricular block with pacemaker and recurrent laryngeal nerve palsy). All patients underwent standard titration of stimulation parameters and long-term clinical follow-up. Results: All three patients showed significant and lasting mood stabilization within approximately 12 months after right-sided VNS implantation. Hospital admission rates decreased markedly, and in two cases, maintenance electroconvulsive therapy (ECT) was discontinued or notably reduced. In all cases, VNS was generally well tolerated. During right-sided stimulation, no clinically significant bradyarrhythmia, device interactions, or other serious cardiac adverse events were observed. Conclusions: This series highlights the usefulness of right-sided VNS in sustaining long-term mood stability and reducing hospitalizations for patients with highly treatment-resistant, comorbid mood disorders. The findings expand existing epilepsy-focused data on right-sided VNS to the psychiatric field and support systematic evaluation of this approach in future prospective studies. Multidisciplinary coordination is essential to minimize risks and improve outcomes. Additional long-term research is needed to assess its lasting effectiveness, optimal candidate selection, and cost-efficiency in routine clinical practice.
- Open Access
- 17 September 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (9) , 1335
A Systematic Review and Meta-Analysis of Cognitive Effects of rTMS in Caucasian Patients with Mild Cognitive Impairment
In recent years, repetitive transcranial magnetic stimulation (rTMS) has received much attention as a non-invasive, effective treatment modality for mild cognitive impairment (MCI). Although several meta-analyses have reported that rTMS can improve cognitive abilities, improvements in individual memory domains (speech, language, concentration, and memory) are poorly understood. In addition, stimulation parameters may be flawed in studies of global populations because of ethnic differences between Caucasians and Asians. This meta-analysis aimed to systematically characterize the efficacy of different combinations of rTMS parameters on different cognitive domains in Caucasian patients with MCI. We conducted a systematic literature search in Medline PubMed, Pubpsych, and Embase on the use of rTMS in MCI patients through November 2022. Randomized, double-blind, and sham-controlled trials (RCTs) from the Caucasian patient population were included. The studies reported outcome measures for different domains of cognition, such as language, concentration, or memory. Possible effects of covariates were examined using meta-regressions. The search yielded five publications. The analyses found that rTMS improved cognitive functions, memory, concentration, and language in patients with MCI and treatment with rTMS compared with the sham stimulation group. The statistical analysis results of the studies showed that rTMS could improve various cognitive functions, such as memory and concentration, in Caucasian MCI patients. A particular effect was found at a frequency of 10 Hz and stimulation of the LDLPFC. However, further studies are needed to validate these findings and explore more effective stimulation protocols and targets.
- 17 September 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (9) , 1335
Open AccessA Systematic Review and Meta-Analysis of Cognitive Effects of rTMS in Caucasian Patients with Mild Cognitive Impairment
In recent years, repetitive transcranial magnetic stimulation (rTMS) has received much attention as a non-invasive, effective treatment modality for mild cognitive impairment (MCI). Although several meta-analyses have reported that rTMS can improve cognitive abilities, improvements in individual memory domains (speech, language, concentration, and memory) are poorly understood. In addition, stimulation parameters may be flawed in studies of global populations because of ethnic differences between Caucasians and Asians. This meta-analysis aimed to systematically characterize the efficacy of different combinations of rTMS parameters on different cognitive domains in Caucasian patients with MCI. We conducted a systematic literature search in Medline PubMed, Pubpsych, and Embase on the use of rTMS in MCI patients through November 2022. Randomized, double-blind, and sham-controlled trials (RCTs) from the Caucasian patient population were included. The studies reported outcome measures for different domains of cognition, such as language, concentration, or memory. Possible effects of covariates were examined using meta-regressions. The search yielded five publications. The analyses found that rTMS improved cognitive functions, memory, concentration, and language in patients with MCI and treatment with rTMS compared with the sham stimulation group. The statistical analysis results of the studies showed that rTMS could improve various cognitive functions, such as memory and concentration, in Caucasian MCI patients. A particular effect was found at a frequency of 10 Hz and stimulation of the LDLPFC. However, further studies are needed to validate these findings and explore more effective stimulation protocols and targets.
- 17 July 2023
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 33 (10) , 3389-3403
Electroconvulsive therapy in children and adolescents in Europe-a systematic review of the literature complemented by expert information and guideline recommendations
The first documented pediatric use of Electroconvulsive therapy (ECT) occurred in Europe in 1941. Since then, predominantly successful treatments and reasonable side effects have been reported in severely ill minors. Nevertheless, a shy reluctance determines the controversy about ECT in young patients. This study describes the use of ECT in children and adolescents in Europe. We systematically searched the literature concerning the practice of ECT in minors in all 53 European countries. In addition, we surveyed European experts about national practices and compared guidelines for ECT in minors. The search yielded 79 publications from 18 European countries, mainly from Western Europe, Israel, and Turkey. National data were available from eight countries. These showed an interestingly high relationship between the number of minors treated with ECT and the general use of ECT. No persistent deficits or deaths were reported. On the other hand, no randomized clinical trial was found, and many publications lacked relevant information. Accordingly, the appraisal of the evidence in the guidelines varies considerably. Experts from 13 European countries consistently reported infrequent and unsystematic use of ECT in minors. ECT has been used successfully in minors in Europe with reasonable complications and side effects. Adverse effects on the developing brain, as often suspected, have not been scientifically supported in eight decades. Nevertheless, the use of ECT in Europe is sparse and dependent on accidental circumstances. High-quality evidence is needed, as well as improved knowledge and training of child and adolescent psychiatrists.
- 17 July 2023
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 33 (10) , 3389-3403
Electroconvulsive therapy in children and adolescents in Europe-a systematic review of the literature complemented by expert information and guideline recommendations
The first documented pediatric use of Electroconvulsive therapy (ECT) occurred in Europe in 1941. Since then, predominantly successful treatments and reasonable side effects have been reported in severely ill minors. Nevertheless, a shy reluctance determines the controversy about ECT in young patients. This study describes the use of ECT in children and adolescents in Europe. We systematically searched the literature concerning the practice of ECT in minors in all 53 European countries. In addition, we surveyed European experts about national practices and compared guidelines for ECT in minors. The search yielded 79 publications from 18 European countries, mainly from Western Europe, Israel, and Turkey. National data were available from eight countries. These showed an interestingly high relationship between the number of minors treated with ECT and the general use of ECT. No persistent deficits or deaths were reported. On the other hand, no randomized clinical trial was found, and many publications lacked relevant information. Accordingly, the appraisal of the evidence in the guidelines varies considerably. Experts from 13 European countries consistently reported infrequent and unsystematic use of ECT in minors. ECT has been used successfully in minors in Europe with reasonable complications and side effects. Adverse effects on the developing brain, as often suspected, have not been scientifically supported in eight decades. Nevertheless, the use of ECT in Europe is sparse and dependent on accidental circumstances. High-quality evidence is needed, as well as improved knowledge and training of child and adolescent psychiatrists.